Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Dexlansoprazole 60 mg Delayed Release Capsules and Esomeprazole 40 mg Delayed Release Capsules on Bone Homeostasis in Healthy Postmenopausal Female Subjects.
Phase of Trial: Phase I
Latest Information Update: 06 Mar 2015
At a glance
- Drugs Dexlansoprazole (Primary) ; Esomeprazole
- Indications Bleeding ulcer; Erosive oesophagitis; Gastro-oesophageal reflux; Helicobacter infections; NSAID-induced ulcer; Peptic ulcer; Zollinger-Ellison syndrome
- Focus Biomarker; Pharmacodynamics
- Sponsors Takeda
- 02 Mar 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 18 Feb 2014 Status changed from recruiting to active, no longer recruiting, as per ClinicalTrials.gov record.
- 14 Nov 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.